Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Mayer

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|July 23, 2013
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancerErica L Mayer, M E Scheulen, J Beckman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2024
Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysisMichael Untch, David Pérol, Erica L Mayer, et al.
Breast Cancer Research and Treatment|November 29, 2023
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancerErica L Mayer, Nabihah Tayob, Siyang Ren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated MetastasisKelly E Johnson, Jodi A Forward, Mason D Tippy, et al.
Journal of Cancer Survivorship : Research and Practice|November 5, 2017
Randomized trial of a clinic-based weight loss intervention in cancer survivorsJustin C Brown, Rachel L Yung, Anita Gobbie-Hurder, et al.
Annals of Surgical Oncology|April 24, 2014
Sentinel lymph node biopsy in pregnant women with breast cancerAdrienne B Gropper, Katherina Zabicki Calvillo, Laura Dominici, et al.
Nucleic Acids Research|April 23, 2025
DirectHRD enables sensitive scar-based classification of homologous recombination deficiencyRuolin Liu, Eugenia Roberts, Heather A Parsons, et al.
Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.
Annals of Surgical Oncology|September 30, 2023
Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical TrialOlga Kantor, Tari A King, Alyssa Jones, et al.
Breast Cancer Research and Treatment|October 7, 2020
A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancerOtto Metzger Filho, Anita Giobbie-Hurder, Nancy U Lin, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|July 23, 2013
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancerErica L Mayer, M E Scheulen, J Beckman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2024
Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysisMichael Untch, David Pérol, Erica L Mayer, et al.
Breast Cancer Research and Treatment|November 29, 2023
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancerErica L Mayer, Nabihah Tayob, Siyang Ren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated MetastasisKelly E Johnson, Jodi A Forward, Mason D Tippy, et al.
Journal of Cancer Survivorship : Research and Practice|November 5, 2017
Randomized trial of a clinic-based weight loss intervention in cancer survivorsJustin C Brown, Rachel L Yung, Anita Gobbie-Hurder, et al.
Annals of Surgical Oncology|April 24, 2014
Sentinel lymph node biopsy in pregnant women with breast cancerAdrienne B Gropper, Katherina Zabicki Calvillo, Laura Dominici, et al.
Nucleic Acids Research|April 23, 2025
DirectHRD enables sensitive scar-based classification of homologous recombination deficiencyRuolin Liu, Eugenia Roberts, Heather A Parsons, et al.
Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.
Annals of Surgical Oncology|September 30, 2023
Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical TrialOlga Kantor, Tari A King, Alyssa Jones, et al.
Breast Cancer Research and Treatment|October 7, 2020
A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancerOtto Metzger Filho, Anita Giobbie-Hurder, Nancy U Lin, et al.
Pageof 12